Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-4-18
|
pubmed:abstractText |
B-cell chronic lymphocytic leukemia (B-CLL) is typically a low-grade neoplasm with a diploid DNA index and low proliferative activity. Interleukin-2 receptor (IL-2R/CD25) positivity often indicates increased proliferative activity and activation in both T and B lymphocytes. The argyrophilic nucleolar organizer regions (AgNORs) are loops of DNA identified by a silver staining technique and have been correlated with ploidy and proliferative activity. Two distinct AgNOR counting methods have been previously shown to correlate with DNA ploidy and proliferative activity, respectively: the mean AgNOR count (mAgNOR) correlates more with ploidy, and the percentage of nuclei with > or = 5 AgNORs/nucleus (pAgNOR) reflects proliferative activity. We studied bone marrow specimens from 32 patients with B-CLL using both anti-IL-2R on the marrow aspirates and the AgNOR silver stain on marrow biopsy specimens, applying both AgNOR counts. All tumors were CD5+, CD19+, and CD19/CD20+. Sixteen tumors were IL-2R- (< 20% IL-2+ B cells), and 16 were IL-2R+ (> or = 20% IL-2R+ B-cells). No significant difference in morphology of bone marrow involvement was noted in the two groups. A male predominance was noted in the IL-2R+ group of patients (3:1). There was also a preponderance of lambda light chain expression in the IL-2R+ tumors (11/16) compared with the IL-2R- cases (5/16). Except for two cases, all tumors had mAgNOR counts within the diploid range (< 2.4). The 16 IL-2R- tumors had pAgNOR in the range of 0% to 7% (mean, 2.31 +/- 2.18 standard deviation), whereas the IL-2R+ tumors had pAgNOR ranging from 6% to 15% (mean, 10.20 +/- 2.70 standard deviation; P < .0001). This finding suggests that IL-2R+ B-CLL might represent a subgroup of tumors with higher proliferative activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
300-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8135185-Adult,
pubmed-meshheading:8135185-Aged,
pubmed-meshheading:8135185-Aged, 80 and over,
pubmed-meshheading:8135185-Antigens, CD,
pubmed-meshheading:8135185-Bone Marrow,
pubmed-meshheading:8135185-Cell Division,
pubmed-meshheading:8135185-Female,
pubmed-meshheading:8135185-Humans,
pubmed-meshheading:8135185-Immunophenotyping,
pubmed-meshheading:8135185-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:8135185-Male,
pubmed-meshheading:8135185-Middle Aged,
pubmed-meshheading:8135185-Nucleolus Organizer Region,
pubmed-meshheading:8135185-Receptors, Interleukin-2,
pubmed-meshheading:8135185-Sex Distribution,
pubmed-meshheading:8135185-Silver Staining
|
pubmed:year |
1994
|
pubmed:articleTitle |
Cell kinetic analysis of interleukin-2 receptor-tested chronic lymphocytic leukemia using the AgNOR silver stain.
|
pubmed:affiliation |
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston.
|
pubmed:publicationType |
Journal Article
|